102 related articles for article (PubMed ID: 3806617)
1. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. 2. Direct observation, characterization, and reactivity studies of iminocyclophosphamide and related species.
Boyd VL; Summers MF; Ludeman SM; Egan W; Zon G; Regan JB
J Med Chem; 1987 Feb; 30(2):366-74. PubMed ID: 3806617
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic detection of iminocyclophosphamide and its possible role in cyclophosphamide metabolism.
Kwon CH; Kirk MC; Struck RF; Borch RF
J Med Chem; 1987 Jun; 30(6):1110-4. PubMed ID: 3585908
[TBL] [Abstract][Full Text] [Related]
4. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
Borch RF; Hoye TR; Swanson TA
J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
[TBL] [Abstract][Full Text] [Related]
5. 31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites.
Boyd VL; Robbins JD; Egan W; Ludeman SM
J Med Chem; 1986 Jul; 29(7):1206-10. PubMed ID: 3543359
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of activation of 4-hydroxycyclophosphamide.
Borch RF; Millard JA
J Med Chem; 1987 Feb; 30(2):427-31. PubMed ID: 3806624
[TBL] [Abstract][Full Text] [Related]
8. Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism.
Kwon CH; Borch RF; Engel J; Niemeyer U
J Med Chem; 1987 Feb; 30(2):395-9. PubMed ID: 3806619
[TBL] [Abstract][Full Text] [Related]
9. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
Fenselau C; Lehman JP; Myles A; Brandt J; Yost GS; Friedman OM; Colvin OM
Drug Metab Dispos; 1982; 10(6):636-40. PubMed ID: 6130913
[TBL] [Abstract][Full Text] [Related]
10. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR
J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance study of fibrinogen-like peptides and their structure in dimethyl sulfoxide and water.
von Dreele PH; Rae ID; Scheraga HA
Biochemistry; 1978 Mar; 17(6):956-62. PubMed ID: 629953
[TBL] [Abstract][Full Text] [Related]
12. Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate.
Borch RF; Getman KM
J Med Chem; 1984 Apr; 27(4):485-90. PubMed ID: 6708050
[TBL] [Abstract][Full Text] [Related]
13. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
14. Multinuclear NMR (1H, 13C and 19F) spectroscopic re-examination of the solvolytic behaviour of flurazepam dihydrochloride.
Dawson BA; Black DB; Neville GA
J Pharm Biomed Anal; 1995 Apr; 13(4-5):395-407. PubMed ID: 9696548
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
Sonawat HM; Leibfritz D; Engel J; Hilgard P
Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593
[TBL] [Abstract][Full Text] [Related]
17. Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification.
Ludeman SM; Shulman-Roskes EM; Wong KK; Han SY; Anderson LW; Strong JM; Colvin OM
J Pharm Sci; 1995 Apr; 84(4):393-8. PubMed ID: 7629726
[TBL] [Abstract][Full Text] [Related]
18. The interaction of glutathione with 4-hydroxycyclophosphamide and phosphoramide mustard, studied by 31P nuclear magnetic resonance spectroscopy.
Dirven HA; Venekamp JC; van Ommen B; van Bladeren PJ
Chem Biol Interact; 1994 Dec; 93(3):185-96. PubMed ID: 7923439
[TBL] [Abstract][Full Text] [Related]
19. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
[TBL] [Abstract][Full Text] [Related]
20. 1H- and 13C-NMR studies of solutions of hyaluronic acid esters and salts in methyl sulfoxide: comparison of hydrogen-bond patterns and conformational behaviour.
Kvam BJ; Atzori M; Toffanin R; Paoletti S; Biviano F
Carbohydr Res; 1992 Jun; 230(1):1-13. PubMed ID: 1511449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
